PETER FINELLI: Open Payments
NPI 1033310560 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 14 payments from 9 companies in 2025. Trend: 2023 $441 · 2024 $488 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Braeburn Inc. | 1 | $25 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, Auvelity, BRIXADI, Quviviq, CAPLYTA, LOREEV XR, FANAPT.
Industry payments across PA — which companies pay providers there.
